OR AKIVA, Israel--(BUSINESS WIRE)--ITGI (TASE:ITGI) announces today the initiation of its activity in the U.S. market. The company has signed a strategic cooperation agreement with U.S.-based Vascular Solutions, Inc. (NASDAQ:VASC), an international leader in the interventional cardiology device market. The companies will collaborate to complete a U.S. development program and apply to the Food and Drug Administration for approval under the Humanitarian Device Exemption (HDE) process for ITGI’s novel Aneugraft Dx coronary covered stent.
Help employers find you! Check out all the jobs and post your resume.